In vitro activity of cefiderocol against carbapenemase-producing and meropenem-non-susceptible Gram-negative bacteria collected in the Japan Antimicrobial Resistant Bacterial Surveillance.
Shizuo KayamaSayoko KawakamiKohei KondoNorikazu KitamuraLiansheng YuWataru HayashiKoji YaharaYo SugawaraMotoyuki SugaiPublished in: Journal of global antimicrobial resistance (2024)
This is the first large-scale study to systematically demonstrate the efficacy of CFDC against IMP-type carbapenemase-producing strains with known genomic backgrounds.